GPAT3 and hepatocellular carcinoma: In this study, we observed that after interference with DGATs or other GPATs in HCC SR cells were not observed triglyceride levels change and their sensitivity to sorafenib influence, but knocking down GPAT3 resulted in reduced TAG synthesis and increased apoptosis of HCC cells induced by sorafenib.